Is Novo Nordisk A/S (NVO) A Good Stock To Buy Now?

Is NVO a good stock to buy? We came across a bullish thesis on Novo Nordisk A/S on Hated Moats’s Substack by Hated Moats Investors. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S’s share was trading at $42.96 as of June 5th. NVO’s trailing and forward P/E were 10.09 and 12.77 respectively according to Yahoo Finance.

5 Countries with the Highest Rates of Diabetes

Photo by Matt C on Unsplash

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and...